利用大语言模型提升细胞病理学:机遇、挑战与未来方向——ASC临床实践委员会实用综述
本文为美国细胞病理学会临床实践委员会综述,评估大语言模型(LLM)与视觉语言模型在细胞病理学中结构化报告、诊断辅助、质量控制、教育和流程整合的应用证据,区分已有初步证据与仍属假设的应用,讨论幻觉风险、可解释性有限、偏倚、数据隐私、验证缺口和基础设施障碍等部署前挑战,并综述美欧AI医疗器械监管及推荐。
要点
- LLM与视觉语言模型在细胞病理学有多场景应用潜力,但多数证据尚属初步。
- 临床部署前须解决幻觉风险、可解释性有限、偏倚、隐私和验证缺口等挑战。
- 推荐细胞病理学专用基准、多机构验证、透明治理并从低风险应用渐进部署。
核心结论
- 当前环境下LLM有潜力增强细胞病理学实践,但负责任采用需要严格验证及细胞病理学家、AI研究者与监管机构的持续协作。
研究设计与样本
- 美国细胞病理学会临床实践委员会综述,检索并评估LLM与视觉语言模型在细胞病理学应用的当前证据。
主要发现
- 综述涵盖结构化报告、诊断辅助、质量控制、教育和流程整合等应用场景。
- 文中区分了已有初步证据的应用与仍属假设的应用。
- 部署前挑战包括幻觉风险、可解释性有限、偏倚、数据隐私、验证缺口和基础设施障碍。
关键数值与推荐
- 推荐建立细胞病理学专用基准、开展多机构验证、实施透明治理并从低风险应用开始渐进部署。
- 综述涵盖美国与欧盟对AI医疗器械软件的监管格局。
临床怎么用
- 临床采用应优先从低风险应用起步,并依据多机构验证和透明治理逐步推进。
局限性
- 综述指出多数应用证据尚属初步,部分应用仍属假设,且存在验证缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Large language models (LLMs) and vision-language models represent a fundamentally different category of artificial intelligence (AI) compared to prior image analysis approaches in digital pathology, which have largely been based on convolutional neural network architectures. This review from the American Society of Cytopathology Clinical Practice Committee examines the current evidence for LLM and vision-language model applications in cytopathology, including structured reporting, diagnostic assistance, quality control, education, and workflow integration. The distinction between applications with preliminary evidence and those that remain hypothetical is described. A detailed assessment of the challenges that must be addressed before clinical deployment, including hallucination risk, limited explainability, bias, data privacy, validation gaps, and infrastructure barriers is discussed. A review of the regulatory landscape in the United States and European Union as it applies to AI-enabled software as a medical device is provided. Recommendations addressing cytopathology-specific benchmarks, multi-institutional validation, transparent governance, and incremental deployment beginning with low-risk applications are suggested. In the current environment, LLMs have the potential to augment cytopathology practice, but responsible adoption requires rigorous validation and sustained collaboration among cytopathologists, AI researchers, and regulatory bodies.
引用
- Bilal KH, Gibson J, Kim D, et al. Leveraging large language models to enhance cytopathology: Opportunities, challenges, and future directions; a practical review from the ASC Clinical Practice Committee. Cancer Cytopathol. 2026. PMID: 42585107. doi:10.1002/cncy.70134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。